{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:08:18Z","timestamp":1774930098620,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijid.2018.10.004","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T13:45:08Z","timestamp":1539179108000},"page":"82-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America"],"prefix":"10.1016","volume":"77","author":[{"given":"Helio S.","family":"Sader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Streit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia G.","family":"Carvalhaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo E.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2018.10.004_bib0005","series-title":"M07Ed11E. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"CLSI","year":"2018"},{"key":"10.1016\/j.ijid.2018.10.004_bib0010","series-title":"M100Ed28E. Performance standards for antimicrobial susceptibility testing: 28th informational supplement","author":"CLSI","year":"2018"},{"key":"10.1016\/j.ijid.2018.10.004_bib0015","series-title":"Breakpoint tables for interpretation of MIC\u2019s and zone diameters. Version 8.0, January 2018","author":"EUCAST","year":"2018"},{"issue":"12","key":"10.1016\/j.ijid.2018.10.004_bib0020","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/657313","article-title":"Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia","volume":"51","author":"File","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ijid.2018.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-013-0075-6","article-title":"Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia","volume":"73","author":"Frampton","year":"2013","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.ijid.2018.10.004_bib0030","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/jac\/dkv107","article-title":"Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13","volume":"70","author":"Golden","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"13","key":"10.1016\/j.ijid.2018.10.004_bib0035","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/14656566.2017.1363179","article-title":"New treatment options for lower respiratory tract infections","volume":"18","author":"Kocsis","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijid.2018.10.004_bib0040","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2018.10.004_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cger.2016.02.012","article-title":"Bacterial pneumonia in older adults","volume":"32","author":"Marrie","year":"2016","journal-title":"Clin Geriatr Med"},{"issue":"sup1","key":"10.1016\/j.ijid.2018.10.004_bib0050","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1080\/20469047.2017.1409455","article-title":"Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review","volume":"38","author":"Mathur","year":"2018","journal-title":"Paediatr Int Child Health"},{"issue":"8","key":"10.1016\/j.ijid.2018.10.004_bib0055","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1128\/AAC.02976-14","article-title":"Decreased ceftriaxone susceptibility in emerging (35B, 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the USA (2011\u20132012): Ceftaroline remains active in vitro among beta-lactam agents","volume":"58","author":"Mendes","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijid.2018.10.004_bib0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/mdr.2016.0258","article-title":"Ceftaroline activity against multidrug-resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and molecular characterization of a single ceftaroline nonsusceptible isolate","volume":"23","author":"Pfaller","year":"2017","journal-title":"Microb Drug Resist"},{"issue":"9998","key":"10.1016\/j.ijid.2018.10.004_bib0065","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","article-title":"Community-acquired pneumonia","volume":"386","author":"Prina","year":"2015","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ijid.2018.10.004_bib0070","first-page":"1863","article-title":"Community-acquired pneumonia","volume":"370","author":"Wunderink","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2018.10.004_bib0075","series-title":"Product Information","author":"Zinforo\u00ae","year":"2015"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218345508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971218345508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T04:25:44Z","timestamp":1545020744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971218345508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":15,"alternative-id":["S1201971218345508"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2018.10.004","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2018.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}